Inhibrx CEO Mark Lappe's 2022 pay falls 78% to $1M
Inhibrx reports 2022 executive compensation
By ExecPay News
Published: April 13, 2023
Inhibrx reported fiscal year 2022 executive compensation information on April 13, 2023.
In 2022, three Inhibrx executives received on average a compensation package of $916K, a 70% decrease compared to previous year.
Average pay of disclosed executives at Inhibrx
Mark P. Lappe, Chief Executive Officer, received $1M in total, which decreased by 78% compared to 2021. 64% of Lappe's compensation, or $650K, was in salary. Lappe also received $358K in non-equity incentive plan and $15K in other compensation.
Kelly D. Deck, Chief Financial Officer, received a compensation package of $1M, which decreased by 54% compared to previous year. 48% of the compensation package, or $491K, was in option awards.
Brendan P. Eckelman, Chief Scientific Officer, earned $704K in 2022, a 58% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 13, 2023.